Topic · page 13 of 47

Lupus & antiphospholipid syndrome

Systemic and cutaneous lupus erythematosus, lupus nephritis, neuropsychiatric lupus, disease activity, remission and low disease activity, damage, antimalarials and targeted treatment; antiphospholipid antibodies and antiphospholipid syndrome, thrombotic and obstetric

Briefs 481–520 of 1,848 placed here, newest publication first

Briefs in Lupus & antiphospholipid syndrome

Newest publication first

Lupus7 Dec 2025
Prevalence of pulmonary diseases among patients newly diagnosed with systemic lupus erythematosus: A cross-sectional case-series introducing thoracic ultrasound and diaphragmatic ultrasound
Cross-sectional study
Lupus Sci Med7 Dec 2025
Proteomic analysis reveals angiogenesis-related plasma proteins associated with pre-eclampsia in SLE
Cohort study
Rheumatology (Oxford)6 Dec 2025
The increase of monocyte/high-density lipoprotein cholesterol ratio precedes recurrent thrombosis in patients with APS
Cohort study
Ann Rheum Dis5 Dec 2025
B cell depletion and BAFF receptor blockade with ianalumab (VAY736) for the treatment of moderate-to-severe systemic lupus erythematosus: a phase 2 randomised, double-blind, placebo-controlled trial with subsequent open-label treatment
Randomized controlled trial
Lupus Sci Med4 Dec 2025
New efforts to incorporate patient-reported outcomes into lupus clinical trials: report of the community meeting convened by the Lupus Accelerating Breakthroughs Consortium (Lupus ABC), 16–17 October 2024
Guideline or statement
Arthritis Care Res (Hoboken)4 Dec 2025
Identifying High‐Impact Solutions to Address Racial and Ethnic Health Disparities in Lupus: A Consensus‐Based Approach
Guideline or statement
Lupus3 Dec 2025
Comparative efficacy of tacrolimus-based induction therapy with and without mycophenolate mofetil in lupus nephritis: A target trial emulation study
Cohort study
Arthritis Care Res (Hoboken)3 Dec 2025
Serum Soluble Mediator Signatures of Lupus Nephritis: Histologic Features and Response to Treatment
Cohort study
Lupus1 Dec 2025
Racial differences in medication beliefs and adherence barriers among patients with systemic lupus erythematosus
Cross-sectional study
Lupus Sci Med28 Nov 2025
Complete blood count-derived biomarkers as indicators of systemic lupus erythematosus activity: a cross-sectional comparative study
Cross-sectional study
Lupus Sci Med28 Nov 2025
Dysregulated soluble immune mediators and lupus-associated autoantibody specificities inform the development of immune indexes that characterise classified SLE transition and SLE disease activity
Diagnostic or prognostic study
Lupus Sci Med28 Nov 2025
Inflammation in areas of fibrosis precedes loss of kidney function in lupus nephritis
Cohort study
Lupus Sci Med28 Nov 2025
Prevalence and predictive factors associated with sustained remission in SLE: a systematic review
Meta-analysis
Lupus27 Nov 2025
Differential glomerular expression patterns of Th17-related cytokines in Mexican patients with lupus nephritis
Cross-sectional study
Rheumatology (Oxford)27 Nov 2025
Genetic landscape of early-onset systemic lupus erythematous in India
Cohort study
Rheumatology (Oxford)27 Nov 2025
Salience network dysfunction in SLE: convergent roles of complement activation and altered serotonergic signaling
Mechanistic study
Lupus26 Nov 2025
The polish validation of a disease-specific patient-reported outcome measure of systemic lupus erythematosus
Cross-sectional study
Arthritis Res Ther25 Nov 2025
Urinary acetylated protein as a biomarker of lupus nephritis: a prospective cohort study
Cohort study
Lupus24 Nov 2025
Efficacy of adding belimumab to hydroxychloroquine for patients with serologically active clinically quiescent in systemic lupus erythematosus: A retrospective study
Cohort study
Lupus Sci Med24 Nov 2025
Dietary Intervention for Systemic Lupus Erythematosus patients based on HLA-DQ2 and DQ8 genotyping (DISH): a protocol for a randomised controlled study
Trial design
Clin Exp Rheumatol24 Nov 2025
Stratification of primary antiphospholipid syndrome by mechanistic immunophenotype: machine learning identifies distinct T-cell and T-bet+CD11c+ B cell-driven patient clusters
Cross-sectional study
Arthritis Care Res (Hoboken)22 Nov 2025
Hydroxychloroquine Associated With Lower Glomerular Filtration Rate Decline in Lupus Nephritis
Cohort study
Arthritis Care Res (Hoboken)21 Nov 2025
Reduction in Renal Relapse and Preservation of Long‐Term Kidney Function After Lupus Low Disease Activity in Patients With Lupus Nephritis
Cohort study
Lupus20 Nov 2025
Assessment of subclinical cardiovascular risk in systemic lupus erythematosus utilizing carotid ultrasound and clinical evaluation
Cross-sectional study
Lupus Sci Med19 Nov 2025
Development and validation of nomograms for predicting activity index and tubulointerstitial lesions in lupus nephritis: a multicentre study
Diagnostic or prognostic study
Lancet Rheumatol19 Nov 2025
Cardiovascular risk factor control in antiphospholipid syndrome, and differences between primary and systemic lupus erythematosus-related antiphospholipid syndrome (SURF-SLE and APS project): a cross-sectional study of 1003 individuals from 11 countries
Cross-sectional study
Ann Rheum Dis19 Nov 2025
Clinical and biologic predictors of thrombosis in persistently antiphospholipid antibody-positive patients: Prospective analysis of the International APS ACTION Clinical Database and Repository (‘Registry’)
Cohort study
Ann Rheum Dis19 Nov 2025
Development and validation of a EULAR disease activity score in antiphospholipid syndrome
Diagnostic or prognostic study
Rheumatology (Oxford)18 Nov 2025
Predictors of damage accrual by organ domain in systemic lupus erythematosus
Cohort study
Lupus17 Nov 2025
Delayed diagnosis contributes to increased thrombotic burden and independently predicts severe organ damage in thrombotic antiphospholipid syndrome
Cohort study
Lupus17 Nov 2025
Distinct autoantibody patterns and clinical phenotypes by sex in Chinese systemic lupus erythematosus: A cross-sectional study
Cross-sectional study
J Rheumatol15 Nov 2025
The Renal Activity Index for Lupus: Validation for Prediction of Kidney Inflammation in Adult Patients With Lupus Nephritis
Secondary analysis
J Rheumatol15 Nov 2025
Time Trends in Acute Coronary Syndrome Hospitalizations and Outcomes in Patients With Systemic Lupus Erythematosus: A United States Inpatient Cohort Analysis
Cohort study
J Rheumatol15 Nov 2025
The Burden of Enthesitis, Inflammatory Arthritis, and Tenosynovitis on Musculoskeletal Ultrasound in Systemic Lupus Erythematosus: A Scoping Review
Research article
J Rheumatol15 Nov 2025
Performance of Risk Score Calculators in the Identification of Coronary Artery Calcification in Patients With Systemic Lupus Erythematosus
Secondary analysis
Arthritis Res Ther13 Nov 2025
Inflammation-related proteomics of extracellular vesicles as novel biomarkers for systemic lupus erythematosus revealed by proximity extension assay
Cross-sectional study
Lupus13 Nov 2025
A high level of sTREM-1 predicts occurrence of thrombosis, obstetrical event or death in a prospective cohort of patients with antiphospholipid antibodies and/or systemic lupus. Results of the APLART study
Cohort study
Lupus Sci Med13 Nov 2025
Phenotypically driven subgroups of primary antiphospholipid syndrome-associated thrombocytopenia display distinct outcomes: a prospective cohort study with cluster analysis
Cohort study
Rheumatology (Oxford)13 Nov 2025
Primary antiphospholipid syndrome and the kidney: biopsy-proven insights from two referral Italian centres
Case-control study
Lancet12 Nov 2025
Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in China
Cohort study

All 1,848 Briefs in ExploreShowing Briefs 481–520 of 1,848, newest first